Adjuvanted Seasonal Recombinant QVLP Influenza Vaccine in Adults 65 Years of Age and Older
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 400
Summary
- Conditions
- Influenza
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: RandomizedIntervention Model: Sequential AssignmentMasking: None (Open Label)Masking Description: Partially-BlindedPrimary Purpose: Prevention
Participation Requirements
- Age
- Between 65 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04622592
- Collaborators
- Not Provided
- Investigators
- Study Director: Brian J Ward, MD Medicago